A Randomized Crossover Study of Medroxyprogesterone Acetate and Diane-35 in Adolescent Girls with Polycystic Ovarian Syndrome

Abstract Objective To investigate the effects of 4-month treatment of medroxyprogesterone acetate (MPA) and Diane-35 on the clinical and biochemical features of hyperandrogenism and quality of life of adolescent girls with polycystic ovarian syndrome (PCOS). Design A prospective, randomized, cross-o...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of pediatric & adolescent gynecology 2014-06, Vol.27 (3), p.166-171
Hauptverfasser:	Chung, Jacqueline P.W., MBChB, MRCOG, FHKAM, FHKCOG, Yiu, Alice K.W., MBChB, MRCOG, FHKAM, FHKCOG, Chung, Tony K.H., MBBS, MD, FRANZCOG, FAMS, FHKCOG, FHKAM, FRCOG, Chan, Symphorosa S.C., MBChB, FRCOG, FHKAM, FHKCOG
Format:	Artikel
Sprache:	eng
Schlagworte:	Acne Vulgaris - drug therapy Adolescent Adolescents Androgen Antagonists - therapeutic use Cross-Over Studies Cyproterone acetate Cyproterone Acetate - therapeutic use Drug Combinations Ethinyl Estradiol - therapeutic use Female Follicle Stimulating Hormone - blood Hirsutism - drug therapy Humans Hyperandrogenism - blood Hyperandrogenism - drug therapy Hyperandrogenism - etiology Luteinizing Hormone - blood Medroxyprogesterone acetate Medroxyprogesterone Acetate - therapeutic use Obstetrics and Gynecology Pediatrics Polycystic ovarian syndrome Polycystic Ovary Syndrome - blood Polycystic Ovary Syndrome - complications Polycystic Ovary Syndrome - drug therapy Prospective Studies Quality of Life Severity of Illness Index Testosterone - blood Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!